India ’s Hetero pulls heart drug from U.S. amid cancer risk probes
A unit of India ’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Diovan | Health | Heart | India Health | USA Health | Websites